Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines

Cancer Biology and Therapy

Volumn 14, Issue 1, 2013, Pages 29-38

  Sherif, Zaki A ^a   Sultan, Ahmed S ^b,c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c Alexandria University Faculty Of Science   (Egypt)

Author keywords

Caveolin 1; Li Fraumeni syndrome; Non cancerous skin fibroblasts; p53

Indexed keywords

CAVEOLIN 1; ETOPOSIDE; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; AUTOREGULATION; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; FAMILIAL CANCER; GENE EXPRESSION; GENE MUTATION; HELA CELL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SKIN FIBROBLAST;

CAVEOLIN 1; CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LI-FRAUMENI SYNDROME; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84872166388     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.22621     Document Type: Article

References (37)

1. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10; PMID:11099028; http://dx.doi.org/10.1038/35042675.
2. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24:2899-908; PMID:15838523; http://dx.doi.org/10.1038/ sj.onc.1208615.
3. Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev 2006; 20:236-52; PMID:16418486; http://dx.doi.org/10. 1101/ gad.1372606.
4. Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, Lisanti MP. Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol 2012; 7:423-67; PMID:22077552; http://dx.doi.org/10.1146/annurev-pathol-011811-120856.
5. Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004; 84:1341-79; PMID:15383654; http://dx.doi.org/10.1152/physrev.00046.2003.
6. Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 2005; 280:25134-45; PMID:15802273; http://dx.doi.org/10.1074/jbc.M501186200.
7. Galbiati F, Volonté D, Liu J, Capozza F, Frank PG, Zhu L, et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001; 12:2229-44; PMID:11514613.
8. Palo AK, Sahu P, Choudhury RC. Etoposide-induced cytogenotoxicity in mouse spermatogonia and its potential transmission. J Appl Toxicol 2005; 25:94-100; PMID:15744785; http://dx.doi.org/10.1002/jat.1040.
9. Bartholomew JN, Volonte D, Galbiati F. Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/ p53-mediated pathway. Cancer Res 2009; 69:2878-86; PMID:19318577; http://dx.doi.org/10.1158/0008-5472.CAN-08-2857.
10. Bist A, Fielding CJ, Fielding PE. p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism. Biochemistry 2000; 39:1966-72; PMID:10684646; http://dx.doi.org/10.1021/ bi991721h.
11. Shajahan AN, Wang A, Decker M, Minshall RD, Liu MC, Clarke R. Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity. J Biol Chem 2007; 282:5934-43; PMID:17190831; http://dx.doi.org/10.1074/jbc.M608857200.
12. Schlegel A, Schwab RB, Scherer PE, Lisanti MP. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. J Biol Chem 1999; 274:22660-7; PMID:10428847; http://dx.doi.org/10.1074/jbc.274.32.22660.
13. Sotgia F, Williams TM, Schubert W, Medina F, Minetti C, Pestell RG, et al. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. Am J Pathol 2006; 168:292-309; PMID:16400031; http://dx.doi.org/ 10.2353/ajpath.2006.050429.
14. Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB, et al. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle 2005; 4:1817-25; PMID:16294037; http://dx.doi.org/10.4161/cc.4.12.2199.
15. Razani B, Altschuler Y, Zhu L, Pestell RG, Mostov KE, Lisanti MP. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry 2000; 39:13916-24; PMID:11076533; http://dx.doi.org/10.1021/ bi001489b.
16. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC, Mellon JK. Caveolin-1 expression is associated with high-grade bladder cancer. Urology 2001; 58:811-4; PMID:11711373; http://dx.doi.org/10.1016/S0090-4295(01)01337-1.
17. Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Am J Clin Pathol 2003; 120:93-100; PMID:12866378; http://dx.doi.org/10.1309/292NHAYNWAVREJ37.
18. Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, et al. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 2002; 94:929-33; PMID:11920460; http://dx.doi.org/10.1002/cncr.10329.
19. Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett 1998; 439:368-72; PMID:9845355; http://dx.doi.org/10.1016/S0014-5793(98)01354-4.
20. Yang G, Truong LD, Wheeler TM, Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res 1999; 59:5719-23; PMID:10582690.
21. Lapshina MA, Parkhomenko II, Terentiev AA. Two forms of the nuclear matrix-bound p53 protein in HEK293 cells. Ann N Y Acad Sci 2006; 1090:177-81; PMID:17384260; http://dx.doi.org/10.1196/ annals.1378.019.
22. Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Adv Enzyme Regul 2006; 46:163-75; PMID:16857240; http://dx.doi.org/10.1016/j.advenzreg.2006.01.022.
23. Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene 2005; 24:1338-47; PMID:15592498; http://dx.doi.org/10.1038/ sj.onc.1208337.
24. Wiebe JP, Lewis MJ. Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)- hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells. BMC Cancer 2003; 3:9; PMID:12659654; http://dx.doi.org/10.1186/1471-2407-3-9.
25. Anderson WA, Perotti ME, McManaway M, Lindsey S, Eckberg WR. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes. J Submicrosc Cytol 1984; 16:673-90; PMID:6438351.
26. Soto AM, Murai JT, Siiteri PK, Sonnenschein C. Control of cell proliferation: evidence for negative control on estrogen-sensitive T47D human breast cancer cells. Cancer Res 1986; 46:2271-5; PMID:3697972.
27. Xie D, Miller CW, O'Kelly J, Nakachi K, Sakashita A, Said JW, et al. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem 2001; 276:14187-94; PMID:11297518.
28. Hung KF, Lin SC, Liu CJ, Chang CS, Chang KW, Kao SY. The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med 2003; 32:461-7; PMID:12901727; http://dx.doi.org/10.1034/j.1600-0714.2003.00185.x.
29. Tanase CP, Dima S, Mihai M, Raducan E, Nicolescu MI, Albulescu L, et al. Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. J Mol Histol 2009; 40:23-9; PMID:19160064; http://dx.doi.org/10.1007/s10735-008-9209-7.
30. Bender FC, Reymond MA, Bron C, Quest AF. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 2000; 60:5870-8; PMID:11059785.
31. Glait C, Tencer L, Ravid D, Sarfstein R, Liscovitch M, Werner H. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways. Exp Cell Res 2006; 312:3899-908; PMID:17014845; http://dx.doi.org/10.1016/j.yexcr.2006.08.016.
32. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288:C494-506; PMID:15692148; http://dx.doi.org/10.1152/ajpcell.00458.2004.
33. Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55:5187-90; PMID:7585571.
34. Lee YS, Marks AR, Gureckas N, Lacro R, Nadal-Ginard B, Kim DH. Purification, characterization, and molecular cloning of a 60-kDa phosphoprotein in rabbit skeletal sarcoplasmic reticulum which is an isoform of phosphoglucomutase. J Biol Chem 1992;267:21080-8; PMID:1328221.
35. Sherif ZA, Nakai S, Pirollo KF, Rait A, Chang EH. Downmodulation of bFGF-binding protein expression following restoration of p53 function. Cancer Gene Ther 2001; 8:771-82; PMID:11687900; http://dx.doi.org/10.1038/sj.cgt. 7700361.
36. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30:e15; PMID:11842121; http://dx.doi.org/10.1093/nar/30.4.e15.
37. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348:747-9; PMID:2259385; http://dx.doi.org/10.1038/ 348747a0